CARMEN CARDINALE: Open Payments
NPI 1952704702 · DELMAR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 27 payments from 5 companies in 2025. Trend: 2023 $567 · 2024 $457 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $259 |
| ABBVIE INC. | 4 | $104 |
| PFIZER INC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Organon LLC | 1 | $5 |
Products named: TRELEGY ELLIPTA, SHINGRIX, UBRELVY, VRAYLAR, LINZESS, NURTEC ODT, AREXVY, GEMTESA.
Industry payments across NY — which companies pay providers there.
